SCHEMBL487450

SCHEMBL487450

CC(C)c1ccc2cc(O)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
UGT2B7 P16662 1/20 0.52
TRPA1 O75762 1/20 0.48
PTGS1 P23219 1/20 0.48
CACNA1C Q13936 1/20 0.48
HSD17B10 Q99714 2/20 0.47
CYP2C9 P11712 2/20 0.47
HIF1A Q16665 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
ALOX12 P18054 1/20 0.47
HTT P42858 1/20 0.47
ESR1 P03372 7/20 0.46
ESR2 Q92731 7/20 0.46
CYP3A4 P08684 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12356631 0.95 ESR1 (0.50) CYP1A2UGT2B7TRPA1PTGS1CACNA1C
SCHEMBL20398782 0.86 CYP1A2 (0.50) CYP1A2UGT2B7HSD17B10CYP2C9HIF1A
Hydrogen Peroxide SCHEMBL9172508 0.85 UGT2B7 (0.60) CYP1A2UGT2B7TRPA1PTGS1CACNA1C
Hydrogen Peroxide SCHEMBL9840257 0.85 UGT2B7 (0.60) CYP1A2UGT2B7TRPA1PTGS1CACNA1C
SCHEMBL30031337 0.85 UGT2B7 (0.58) CYP1A2UGT2B7TRPA1PTGS1CACNA1C
SCHEMBL181347 0.85 UGT2B7 (0.58) CYP1A2UGT2B7TRPA1PTGS1CACNA1C
SCHEMBL15853505 0.84 UGT2B7 (0.67) CYP1A2UGT2B7HSD17B10CYP2C9HIF1A
SCHEMBL9118979 0.84 UGT2B7 (0.67) CYP1A2UGT2B7HSD17B10CYP2C9HIF1A
Water SCHEMBL10391367 0.83 UGT2B7 (0.56) CYP1A2UGT2B7TRPA1PTGS1CACNA1C
Water SCHEMBL9862280 0.83 UGT2B7 (0.56) CYP1A2UGT2B7TRPA1PTGS1CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5286902-A Process for preparation of 2-(6-methoxy-2-naphthyl)propionic acid and intermediates therefor utilizing 2,6-diisopropylnaphthalene KOCH INDUSTRIES, INC. (US) 1994-02-15 US claimed
US-5041634-A Process for the preparation of carboxylated aromatic hydroxy compounds CIBA-GEIGY CORPORATION (US) 1991-08-20 US claimed
EP-0320452-A2 Process for preparing carboxylated aromatic hydroxy derivatives CIBA-GEIGY AG (CH) 1989-06-14 EP claimed
JP-3227948-A None JP disclosed
US-12030853-B2 MASP-2 inhibitors and methods of use OMEROS CORPORATION (US) 2024-07-09 US disclosed
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-03 US disclosed
US-20230212144-A1 5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT TRINEURO (KR) 2023-07-06 US disclosed
US-20230212144-A1 5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT TRINEURO (KR) 2023-07-06 US disclosed
US-20230167081-A1 5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-06-01 US disclosed
US-20230167081-A1 5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-06-01 US disclosed
US-20230161251-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-25 US disclosed
US-5003113-A Process of producing isopropylnaphthols MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-03-26 US disclosed
US-4996372-A In a basic aqueous solution, then acid cleaving in the presence of hydrogen peroxide MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-02-26 US disclosed
EP-0370729-A1 Process for producing isopropylnaphthols MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-05-30 EP disclosed
US-4929771-A Process for the preparation of alkyl-substituted phenols or naphthols CIBA-GEIGY CORPORATION (US) 1990-05-29 US disclosed
US-4906790-A Method of oxidizing secondary alkyl substituted naphtalenes and a process of producing isopropylnaphthols MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-03-06 US disclosed
EP-0320451-A2 Process for preparing alkyl-substituted phenols or naphthols CIBA-GEIGY AG (CH) 1989-06-14 EP disclosed
EP-0320452-A2 Process for preparing carboxylated aromatic hydroxy derivatives CIBA-GEIGY AG (CH) 1989-06-14 EP disclosed
EP-0308133-A1 A method of oxidising secondary alkyl substituted naphthalenes MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-03-22 EP disclosed
EP-0239643-A1 PROCESS FOR OXIDIZING 2,6-DIISOPROPYLNAPHTHALENE MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1987-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230161251-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM PYM1, OR10J3, C5 CYP1A2 1933/4885UGT2B7 4692/4885TRPA1 1953/4885
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM OR10J3, PYM1, AP1M1 CYP1A2 833/4885UGT2B7 4124/4885TRPA1 2461/4885
US-20230167081-A1 5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS IKZF1, IKZF3, IKZF2 CYP1A2 2512/4885UGT2B7 3977/4885TRPA1 4704/4885
US-20230212144-A1 5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT HTR5A, HTR2C, TPH1 CYP1A2 336/4885UGT2B7 653/4885TRPA1 4522/4885
US-12030853-B2 MASP-2 inhibitors and methods of use MASP2, METAP2, SPINT2 CYP1A2 4271/4885UGT2B7 3970/4885TRPA1 4840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.